By Paul Ebeling on June 12, 2017No Comment The US Food and Drug Administration has asked Endo Pharmaceuticals (NASDAQ:ENDP) to stop selling its reformulated, extended-release painkiller, Opana ER, after concluding the drugs’s risks outweigh its benefits.
It’s the 1st time the FDA has asked a drug-maker to remove an opioid painkiller from the market.
The agency said it has seen a “significant shift” from people crushing and snorting Opana ER to get high to injecting it.
“We are facing an opioid epidemic – a public health crisis, and we must take all necessary steps to reduce the scope of opioid misuse and abuse,” FDA Commissioner Dr.
addicted, deaths, drug, ENDP, FDA, heroin, maker, market, opioid, painkiller, remove FDA Asked a Drug-maker to Remove Opioid Painkiller from Market added by Paul Ebeling on June 12, 2017View all posts by Paul Ebeling → Enter Email * First Name * Last Name *